Comparative Study of Phala Ghrita and Brihat Shatavari Ghrita Uttarabasti on Endometrial Receptivity in Unexplained Infertility

A Randomized Clinical Trial to Compare the Efficacy of Phala Ghrita Uttarabasti and Brihat Shatavari Ghrita Uttarabasti on Endometrial receptivity in Unexplained Infertility - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/095398

Enrollment

Registered

2025-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N979- Female infertility, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Married female patients between age group 20 years to 40 years. Patients diagnosed as a case of unexplained infertility with B/l patent fallopian tubes, positive ovulatory status, and normal uterine cavity. Normal semen analysis of partner

Exclusion criteria

Exclusion criteria: Women with known cause of infertility. Known case of uro-genital infections, reproductive tract disorders, sexually transmitted diseases and anatomical defect of reproductive/urogenital tract. Known case of medical co morbidity (diabetes mellitus, hypothyroidism) .

Design outcomes

Primary

Measure	Time frame
Changes in receptivity and expression of alpha v beta 3 integrin in endometriumTimepoint: 3 menstrual cycle	—

Secondary

Measure	Time frame
safety profile of drugs and Uttarabasti procedureTimepoint: 3 menstrual cycle	—

Countries

India

Contacts

Public ContactDr Shweta Raturi

National Institute of Ayurveda

baruhunt@gmail.com9799997940

Outcome results